Skip to content

High Risk Factor, Clinical Feature, and Follow up of Neonatal Arrhythmia

High Risk Factor, Clinical Feature, and Follow up of Neonatal Arrhythmia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04899596
Enrollment
1
Registered
2021-05-24
Start date
2019-10-01
Completion date
2020-12-31
Last updated
2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Arrhythmia

Brief summary

This study included 189 newborns (77 male,112 female) diagnosed with arrhythmia in the NICU of Children's Hospital of Chongqing Medical University, China, from January 2015 through December 2019. To investigate the high-risk factors, clinical manifestations, and clinical outcomes of neonatal arrhythmia.

Detailed description

The incidence of neonatal arrhythmia is 3.94‰(189/47911), and the mortality of neonatal arrhythmia is 0.21‰(10/47911) within 1 year after birth.

Interventions

OTHERNo intervention

No intervention

Sponsors

Children's Hospital of Chongqing Medical University
CollaboratorOTHER
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Minutes to 28 Days
Healthy volunteers
No

Inclusion criteria

①Newborns admitted in the Department of Neonatology of Children's Hospital Affiliated to Chongqing Medical University from January 2015 to December 2019;② 12-lead ECG and/or 24-hour dynamic ECG suggest arrhythmias, including children with sinus tachycardia and sinus arrhythmia.

Exclusion criteria

not have

Design outcomes

Primary

MeasureTime frameDescription
Electrocardiogramup to 12 weeksA 12-lead electrocardiogram or dynamic electrocardiogram
anti-arrhythmiabefore 1 year oldUse antiarrhythmic medications
deathup to 12 weeksneonates died
recurrencebefore 1 year oldArrhythmia occurs again

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026